Founder & CEO
Helle Funch Nielsen
In 2003 Helle founded Exhalation Technology Ltd with the purpose of developing a device to screen for inflammatory conditions in the airways of horses. In 2006/2007 the scope of Exhalation Technology was extended to also include humans. Today the main focus of Exhalation Technology is in humans.
Prior to her start-ups Helle has experience working for Fisons Pharmaceuticals (1991-94), Fisons/Rhone Poulenc Rorer (1994-99), for Alcon (1999-2000) and for Galderma Products (2000-01).
Helle has broad experience from pharmaceutical industry where she has worked with human asthma products, allergy products and dermatology products.
In 2001 Helle left to set up Equine Healthcare ApS to develop the world leading inhalation device for asthma treatment in horses. Later she developed a second device for horses, a Nebuliser, launched to market end of 2008.
Director Strategy & Business Development
Stig Lytke Brejl
Stig has been with Exhalation Technology since 2012. His focus has been on strategy development and implementation, but during his years at Exhalation Technology he has also gained substantial insight in and practical experience with MedTech product development, quality assurance and regulatory approval. In parallel to his job at Exhalation Technology, Stig has assumed the role as Chairman of the Board at OSAA Innovation, a small Danish start-up developing a mobile solution for IV-therapy.
Stig holds an MSc in Mechanical Engineering as well as a business degree from the Copenhagen Business School. Stig has almost 35 years of professional experience, holding management positions in different companies. Prior to joining Exhalation Technology, Stig worked as an international Management Consultant serving multiple clients across various industries.
